MedTrace Logo

Preimplantation Genetic Testing in Women of Advanced Maternal Age

NCT04167748 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-08-26

No results posted yet for this study

Summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Conditions

  • Infertility, Female

Interventions

PROCEDURE

Preimplantation genetic testing for aneuploidy (PGT-A)

24-chromosome screening for aneuploidy in the preimplantation embryo (blastocyst stage)

Sponsors & Collaborators

  • Genomic Prediction Inc.

    lead INDUSTRY

Principal Investigators

  • Nathan R Treff, PhD · Genomic Prediction

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-05
Primary Completion
2025-11-01
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167748 on ClinicalTrials.gov